Pregestational Diabetes Flashcards
What are maternal risks of pregnancy in patients with pre-existing type 2 DM?
-Preeclampsia -Gestational hypertension -Cesarean section -Perineal trauma -Hemorrhage
What are fetal risks of pregnancy in patients with pre-existing type 2 DM?
-Polyhydramnios -Fetal macrosomia -Shoulder dystocia -Birth trauma -Preterm delivery
What are maternal risks of pregnancy in patients with type 1 DM?
-Preeclampsia -Gestational hypertension -Cesarean section -Perineal trauma -Hemorrhage -DKA -Renal disease -Retinopathy -Cardiac disease -Hypothyroidism
What are fetal risks of pregnancy in patients with pre-existing type 1 DM?
-Fetal growth restriction -Polyhydramnios -Fetal macrosomia -Shoulder dystocia -Birth trauma -Preterm delivery
How is HbA1c associated with fetal anomalies?
HbA1c of 10% increases the risk of anomalies by 20% - 25%. cardiac anomaly is number 1 cause
What are the most common fetal anomalies complicating pregnancy with preexisting diabetes?
CNS: anencephaly, spina bifida, microcephaly, and holoprosencephaly) Skeletal system: caudal regression syndrome, sacral agenesis, and limb defects Renal system: renal agenesis, hydronephrosis, and ureteric abnormalities Cardiovascular system: transposition of the great vessels, ventricular septal defects, atrial septal defects, coarctation of the aorta, cardiomyopathy, and single umbilical artery Gastrointestinal system: duodenal atresia, anorectal atresia, and small left colon syndrome
What is the pathognomonic fetal anomaly in patients with preexisting diabetes?
Caudal regression
What is a normal hemoglobin A1c level?
HbA1c less than 5.7% Prediabetes: 5.7-6.4% Diabetes: > or 6.5%
What baseline laboratory/non-laboratory evaluation do you perform in pregnancy with type 1/2 DM?
-baseline 24 hour urine protein and creatinine clearance -baseline CBC -baseline CMP -add TSH if type 1 DM -baseline ECG if patient has other comorbidities -baseline echocardiogram if ECG is abnormal or with other comorbidities -Assess for proliferative retinopathy with ophthalmology consultation -Podiatry referral pending physical exam and symptoms -Assess immunity to flu and pneumococcal pneumonia
Outline your antepartum management of patients with type 1 and type 2 DM in pregnancy
Establish due date in the first trimester and assess for NT Detailed anatomic survey at 18-20 weeks Fetal echocardiogram at 20-22 weeks Fetal growth monthly Antenatal testing at 32 weeks twice weekly Delivery between 39 weeks and 39 weeks and 6 days if stable Deliver after 36 weeks if uncontrolled DM
How do you counsel patients on continuing metformin in pregnancy?
First line and gold standard is insulin. It is effective and does not cross the placenta. 0.7–0.8 units/kg actual body weight/day in the first trimester, to 0.8–1 units/kg/day in the second trimester, to 0.9–1.2 units/kg/day in the third trimester. Metformin was not suspected of increasing the risk of birth defects in a rat study; however, the reported data are not the kind typically used to evaluate pregnancy risk. Human experience with metformin in pregnancy has been reassuring, although the number of exposed pregnancies is limited.
How do you counsel the patient with DM on nutritional requirements during pregnancy?
Carbohydrate allocation ranges might be 30–45 g at breakfast, 45–60 g at lunch and dinner, and 15-g snacks approximately 2–3 hours after each meal.
What are your target glucose values in pregnancy?
Fasting: <95mg/dL 1 hour glucose postprandial: <140mg/dL 2 hour glucose postprandial: <120mg/dL
How does diagnosis of diabetic retinopathy impact pregnancy outcome?
Screening for retinopathy by a qualified ophthalmologist is recommended before pregnancy and again during the first trimester for patients with pregestational diabetes because of the demonstrated effectiveness of laser photocoagulation therapy in arresting progression.
How does pregnancy impact diabetic retinopathy progression?
Progression to proliferative diabetic retinopathy occurred in only 2.2% of their subjects, and moderate progression occurred in 2.8%. However, progression was significantly greater in women who had had diabetes for more than 10 years (10% versus 0%).